NSAV ANNOUNCES CORRECTIVE PRESS RELEASE FOR THE HEARTRESCUE CHINA PROGRAM

Cresco, PA., April 20, 2018 -- Net Savings Link, Inc. (OTC: NSAV), a medical technology and software company, announced the correction of a February 15, 2018 press release and subsequent Twitter messages, in reference to NSAV’s relationship to the HeartRescue China Program. NSAV had previously announced that Medtronic PLC ( http://www.medtronic.com ) was the lead sponsor of the project, when the press release should have stated that the Medtronic Foundation ( http://www.medtronic.com/us-en/about/foundation.html ) is the project’s lead sponsor. NSAV would like to sincerely apologize to Medtronic PLC and the Medtronic Foundation for this error.

The HeartRescue China program is led by RTI International ( https://www.rti.org ), a US-based research institute, in partnership with NSAV’s subsidiary, Shanghai based Vital Strategic Research Institute (VSRI) through a subcontract, in addition to other partners.  It is funded and sponsored by the Medtronic Foundation.  The program aims to improve access and quality of care for patients suffering from acute cardiovascular disease (CVD)  in China.  Over 1 million Chinese died each year from CVD of all types, which now the world’s leading cause of death. For more information, please visit the project websites below.

http://www.heartrescueproject.com/heartrescue-project-partners/international-partners/heartrescue-global-china

http://www.heartrescueproject.com

NSAV’s subsidiary, VSRI, is a medical research firm with a long history of expertise in design of clinical trials and global research. VSRI has collaborated with pharmaceutical giants such as Eli Lilly, Pfizer and Bristol-Myers Squibb.

James Tilton, president of NSAV stated, “We greatly appreciate the support that the Medtronic Foundation has provided to the HeartRescue Global Project. Without this support, there would be no project or opportunity to both save and improve the lives of Chinese people who suffer from acute cardiovascular disease.”

NSAV's vision is the establishment of a fully integrated technology and software company that provides turnkey technological and software solutions to the medical industry. Over time, NSAV plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services, patents and trademarks and information technology.

For further information please contact NSAV at 1 (585) 520-2102 or [email protected]

The NSAV corporate email address is [email protected]

The NSAV corporate website can be accessed at http://nsavholdinginc.com

The NSAV Twitter account can be accessed at  https://twitter.com/NSAV_MJTechCo

The NSAV Facebook account can be accessed at  https://www.facebook.com/NSAVHolding

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to bse accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person.

Contact 
Investor Growth LLC
[email protected]
585-520-2102